Skip to main content
SpringerLink
Log in

Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

In this study, the susceptibility of two isolates of Fasciola hepatica—the Fairhurst and Oberon isolates—to treatment with triclabendazole was investigated, both in vivo and in vitro. The Fairhurst isolate originated in England, but has since been maintained in Australia; the Oberon isolate originated in Australia. Triclabendazole had a very high efficacy against the Fairhurst isolate. In sheep (dose: 10 mg/kg), the efficacy ranged from 78.4% at 2 weeks post-infection to 98.5% at 6 weeks post-infection. In cattle (dose: 12 mg/kg) efficacy was 89% at 2 weeks post-infection and 100% at 12 weeks. In contrast, against the Oberon isolate, triclabendazole had 0% efficacy against 2-week-old flukes in sheep (dose: 10 mg/kg) and 5% against 4-week-old flukes. Surface changes to flukes of the two isolates were assessed by scanning electron microscopy following treatment in vitro for 24 h in triclabendazole sulphoxide (15 and 50 μg/ml). Disruption took the form of blebbing, swelling and furrowing of the tegument and was greater in the Fairhurst than the Oberon isolate. Surface changes generally were more severe in the anterior than posterior region of the fluke and the dorsal surface was also consistently more severely affected than the ventral surface. Disruption was more severe at the higher drug concentration for both isolates. The morphological data is consistent with the efficacy data, which indicates that the Fairhurst isolate of F. hepatica is susceptible to triclabendazole treatment, whilst the Oberon isolate is refractory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1 Fig. 2 Fig. 3 Fig. 4 Fig. 5 Fig. 6 Fig. 7 Fig. 8
Fig. 9 Fig. 10 Fig. 11 Fig. 12 Fig. 13 Fig. 14 Fig. 15 Fig. 16
Fig. 17 Fig. 18 Fig. 19 Fig. 20 Fig. 21 Fig. 22 Fig. 23 Fig. 24
Fig. 25 Fig. 26 Fig. 27 Fig. 28 Fig. 29 Fig. 30 Fig. 31 Fig. 32

Similar content being viewed by others

References

  • Boray JC (1985) Flukes of domestic animals. In: Gaafar SM, Howard WE, Marsh RE (eds) Parasites, pests and predators. Elsevier, Amsterdam, pp 179–218

  • Boray JC (1990) Drug resistance in Fasciola hepatica. In: Boray JC, Martin PJ, Roush RT (eds) Resistance of parasites to antiparasitic drugs. MSD AGVET, Rahway, N.J., pp 51–60

  • Boray JC (1997) Chemotherapy of infections with Fasciolidae. In: Boray JC (ed) Immunology, pathobiology and control of fasciolosis. MSD AGVET, Rahway, N.J.,pp 83–97

  • Boray JC, De Bono D (1989) Drug resistance in Fasciola hepatica. In: Outteridge PM, Richards RB (eds) Australian advances in veterinary science 1989. The Australian Veterinary Association, pp166–169

  • Buchanan JF, Fairweather I, Brennan GP, Trudgett A, Hoey EM (2003) Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole (“Valbazen”). Parasitology 126:141–153

    Article  CAS  PubMed  Google Scholar 

  • Coles GC (1986) Anthelmintic activity of triclabendazole. J Helminthol 60:210–212

    CAS  PubMed  Google Scholar 

  • Coles GC, Stafford KA (2001) Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. Vet Rec 148:723–724

    CAS  PubMed  Google Scholar 

  • Coles GC, Rhodes AC, Stafford KA (2000) Activity of closantel against adult triclabendazole-resistant Fasciola hepatica. Vet Rec 146:504

    CAS  PubMed  Google Scholar 

  • Fairweather I, Boray JC (1999) Fasciolicides: efficacy, actions, resistance and its management. Vet J 158:1–32

    Article  PubMed  Google Scholar 

  • Gaasenbeek CPH, Moll L, Cornelissen JBWJ, Vellema P, Borgsteede FHM (2001) An experimental study on triclabendazole resistance of Fasciola hepatica in sheep. Vet Parasitol 95:37–43

    Article  CAS  PubMed  Google Scholar 

  • Hennessy DR, Lacey E, Steel JW, Prichard RK (1987) The kinetics of triclabendazole disposition in sheep. J Vet Pharmacol Ther 10:64–72

    CAS  PubMed  Google Scholar 

  • McKinstry B, Fairweather I, Brennan GP, Forbes AB (2003) Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax). Parasitol Res 91:251–263

    Article  CAS  PubMed  Google Scholar 

  • Meaney M, Fairweather I, Brennan GP, Ramasamy P, Subramanian PB (2002) Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole. Parasitol Res 88:315–325

    Article  CAS  PubMed  Google Scholar 

  • Meaney M, Fairweather I, Brennan GP, McDowell LSL, Forbes AB (2003) Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes. Parasitol Res 91:238–250

    Article  CAS  PubMed  Google Scholar 

  • Miller CMD, Howell MJ, Boray JC (1994) Glutathione S-transferases as markers of salicylanilide resistance in isolates of Fasciola hepatica. Int J Parasitol 24:533–542

    Article  CAS  PubMed  Google Scholar 

  • Mitchell G (2002) Update on fasciolosis in cattle and sheep. In Practice 24:378–385

    Google Scholar 

  • Mitchell GBB, Maris L, Bonniwell MA (1998) Triclabendazole-resistant liver fluke in Scottish sheep. Vet Rec 143:399

    CAS  Google Scholar 

  • Moll L, Gaasenbeek CPH, Vellema P, Borgsteede FHM (2000) Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in the Netherlands. Vet Parasitol 91:153–158

    Article  CAS  PubMed  Google Scholar 

  • Overend DJ, Bowen FL (1995) Resistance of Fasciola hepatica to triclabendazole. Aust Vet J 72:275–276

    CAS  PubMed  Google Scholar 

  • Robinson MW, Trudgett A, Hoey EM, Fairweather I (2002) Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole. Parasitology 124:325–338

    Article  CAS  PubMed  Google Scholar 

  • Robinson MW, Lawson J, Trudgett A, Hoey EM, Fairweather I (2004) The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol Res 92:205–210

    Article  PubMed  Google Scholar 

  • Smeal MG, Hall CA (1983) The activity of triclabendazole against immature and adult Fasciola hepatica in sheep. Aust Vet J 60:329–331

    CAS  PubMed  Google Scholar 

  • Spithill TW, Smooker PM, Copeman DB (1999) Fasciola gigantica: epidemiology, control, immunology and molecular biology. In: Dalton JP (ed) Fasciolosis. CAB International, Wallingford, pp 465–525

  • Stitt AW, Fairweather I (1992) Spermatogenesis in Fasciola hepatica: an ultrastructural comparison of the effects of the anthelmintic, triclabendazole (“Fasinex”) and the microtubule inhibitor, tubulozole. Invertebr Reprod Dev 22:139–150

    CAS  Google Scholar 

  • Stitt AW, Fairweather I (1993) Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex). Parasitol Res 79:529–536

    CAS  PubMed  Google Scholar 

  • Stitt AW, Fairweather I (1994) The effect of the sulphoxide metabolite of triclabendazole (“Fasinex”) on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica. Parasitology 108:555–567

    CAS  PubMed  Google Scholar 

  • Stitt AW, Fairweather I (1996) Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole. Parasitol Res 82:333–339

    Article  CAS  PubMed  Google Scholar 

  • Stitt AW, Fairweather I, Mackender RO (1995) The effect of triclabendazole (“Fasinex”) on protein synthesis by the liver fluke, Fasciola hepatica. Int J Parasitol 25:421–429

    Article  CAS  PubMed  Google Scholar 

  • Thomas I, Coles GC, Duffus K (2000) Triclabendazole-resistant Fasciola hepatica in southwest Wales. Vet Rec 146:200

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Parasite Proteomics and Therapeutics Research Group, School of Biology and Biochemistry, Medical Biology Centre, The Queen’s University of Belfast, 97 Lisburn Road, BT9 7BL, Belfast , Northern Ireland

    S. M. Walker, B. McKinstry, G. P. Brennan, A. Trudgett, E. M. Hoey, H. Fletcher & I. Fairweather

  2. Elizabeth Macarthur Agricultural Institute, NSW Agriculture, Camden, NSW, Australia

    J. C. Boray

  3. Consultant for Veterinary Parasitology Research and Development, 1 Pedaman Place, NSW 2259, Jilliby, Australia

    J. C. Boray

Authors
  1. S. M. Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. McKinstry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. C. Boray
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. P. Brennan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Trudgett
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. M. Hoey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Fletcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I. Fairweather
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Fairweather.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walker, S.M., McKinstry, B., Boray, J.C. et al. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro. Parasitol Res 94, 427–438 (2004). https://doi.org/10.1007/s00436-004-1222-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-004-1222-5

Keywords

Search

Navigation